Miranda M Monk (Miranda Monk)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 6

Top Topics

Methicillin Resistant Staphylococcus Aureus

High Resolution

Respiratory Syndrome Coronavirus

Top Venues

Open forum infectious diseases

Microbiology spectrum

Therapeutic advances in infectious disease

This page only lists publications with an associated author ORCID identifier.

Publications

Miranda M Monk, Nikitha R Patel, Ramy H Elshaboury, David W Kubiak, Sarah P Hammond
Risk of Infective Endocarditis in Streptococcus mitis Bloodstream Infections Among Patients with Neutropenia from Hematologic Malignancies. Open forum infectious diseases 11 (3) (2024)
Miranda M Monk, Nikitha R Patel, Ramy H Elshaboury, David W Kubiak, Sarah P Hammond
Risk of Infective Endocarditis in Streptococcus mitis Bloodstream Infections Among Patients with Neutropenia from Hematologic Malignancies. Open forum infectious diseases 11 (3) (2024)
Miranda M Monk, Nikitha R Patel, Ramy H Elshaboury, David W Kubiak, Sarah P Hammond
Risk of Infective Endocarditis in Streptococcus mitis Bloodstream Infections Among Patients with Neutropenia from Hematologic Malignancies. Open forum infectious diseases 11 (3) (2024)
Miranda M Monk, Nikitha R Patel, Ramy H Elshaboury, David W Kubiak, Sarah P Hammond
Risk of Infective Endocarditis in Streptococcus mitis Bloodstream Infections Among Patients with Neutropenia from Hematologic Malignancies. Open forum infectious diseases 11 (3) (2024)
Miranda M Monk, Ramy Elshaboury, Alexander Tatara, Sandra Nelson, Monique R Bidell
A Case Series of Rifabutin Use in Staphylococcal Prosthetic Infections. Microbiology spectrum 10 (3) (2022)
Ramy H Elshaboury, Miranda M Monk, Lisa M Bebell, Monique R Bidell, Meagan L Adamsick, Ronak G Gandhi, Molly L Paras, Elizabeth L Hohmann, Alyssa R Letourneau
Remdesivir use and outcomes during the FDA COVID-19 emergency use authorization period. Therapeutic advances in infectious disease 8 (2021)